TriSalus Life Sciences, Inc. (TLSI) Revenue History
TriSalus Life Sciences, Inc. (TLSI) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | $12.40M |
| 2023-12-31 | $18.51M |
| 2024-12-31 | $29.43M |
| 2025-12-31 | $45.15M |
How TLSI compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| OCUL | Ocular Therapeutix Inc. | $51.95M |
| GOSS | Gossamer Bio Inc. | $48.47M |
| AQST | Aquestive Therapeutics Inc. | $44.55M |
| VYGR | Voyager Therapeutics Inc. | $40.37M |
| VRCA | Verrica Pharmaceuticals Inc. | $35.58M |
These are five companies in the same sector as TLSI with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get TriSalus Life Sciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("TLSI", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TLSI | $4.06 | -1.69% | 0.20M |
| 3 | ||||
| 4 | ||||
| 5 |